<SEC-DOCUMENT>0001628280-24-048173.txt : 20241118
<SEC-HEADER>0001628280-24-048173.hdr.sgml : 20241118
<ACCEPTANCE-DATETIME>20241118072009
ACCESSION NUMBER:		0001628280-24-048173
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20241118
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241118
DATE AS OF CHANGE:		20241118

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Twist Bioscience Corp
		CENTRAL INDEX KEY:			0001581280
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				462058888
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38720
		FILM NUMBER:		241469758

	BUSINESS ADDRESS:	
		STREET 1:		681 GATEWAY BLVD.
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		800-719-0671

	MAIL ADDRESS:	
		STREET 1:		681 GATEWAY BLVD.
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>twist-20241118.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:912c04d7-fd84-4786-a4ec-b75bcadce53d,g:91d154d6-3648-41c0-b2fb-41e7928a8baf,d:3a0811b090ff46668d96b34fa3db7680-->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>twist-20241118</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-23">0001581280</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="twist-20241118.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001581280</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-18</xbrli:startDate><xbrli:endDate>2024-11-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3a0811b090ff46668d96b34fa3db7680_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Pursuant to Section 13 or 15(d) </span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Date of Report (Date of earliest event reported)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November 18, 2024</ix:nonNumeric></span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Twist Bioscience Corporation</ix:nonNumeric></span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-38720</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">46-2058888</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.25pt;margin-top:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(State or other jurisdiction</span></div><div style="margin-bottom:0.25pt;margin-top:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.25pt;margin-top:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Commission</span></div><div style="margin-bottom:0.25pt;margin-top:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.25pt;margin-top:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(I. R. S. Employer</span></div><div style="margin-bottom:0.25pt;margin-top:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">681 Gateway Boulevard</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">South San Francisco</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">CA</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">94080</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Address of principal executive offices, including ZIP code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">800</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">719-0671</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Not Applicable </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:2.845%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.955%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.25pt;margin-top:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></td></tr></table></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:2.845%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.955%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.25pt;margin-top:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">&#9744;</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:2.845%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.955%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.25pt;margin-top:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:2.845%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.955%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.25pt;margin-top:0.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:31.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.730%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.5pt;margin-top:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Trading</span></div><div style="margin-bottom:0.5pt;margin-top:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.5pt;margin-top:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Name of each exchange</span></div><div style="margin-bottom:0.5pt;margin-top:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">TWST</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Emerging growth company <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#9744;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-bottom:12pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i3a0811b090ff46668d96b34fa3db7680_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 2.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:32.02pt">Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On November 18, 2024, Twist Bioscience Corporation (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) issued a press release announcing its financial results for the fourth quarter and fiscal year ended September 30, 2024. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The information furnished in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed to be &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div id="i3a0811b090ff46668d96b34fa3db7680_10"></div><div style="-sec-extract:summary;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 9.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:32.02pt">Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Exhibits.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:14.249%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.559%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:82.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="twst-20240930xex991.htm">Press release dated November 18, 2024 titled &#8220;Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2024 Financial Results&#8221;</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Data File (formatted as Inline XBRL)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i3a0811b090ff46668d96b34fa3db7680_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURES</span></div><div style="text-indent:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:50.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: November 18, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twist Bioscience Corporation</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Judy Yan</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Judy Yan</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assistant General Counsel and Assistant Secretary</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>twst-20240930xex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="id68af8dbab7b4e56b068b027baa5670e_1"></div><div style="min-height:104.4pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div><div style="text-align:center"><img alt="image_2.jpg" src="image_2.jpg" style="height:81px;margin-bottom:5pt;vertical-align:text-bottom;width:163px"></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">2024</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%"> Financial Results</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8212;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> Record revenue of $313.0 million in Fiscal 2024&#59; Increase of 28% over $245.1 million in Fiscal 2023 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8212;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8212; Record revenue of </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$84.7 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> in Q4FY24&#59; Increase of </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">27%</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> over </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$66.9 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> in Q4FY23, 7th consecutive quarter of sequential growth &#8212; </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8212; Gross margin of 45.1% in Q4FY24&#59; Improvement of 8.5 margin points versus 36.6% in 4QFY23 &#8212; </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8212; Expect revenue in the range of $367 million to $377 million for full year Fiscal </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2025&#59; expect 50% gross margin for 4QFY25 &#8212;</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:115%">SOUTH SAN FRANCISCO, Calif. -- </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">(November&#160;18, 2024)</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#8212; Twist Bioscience Corporation (NASDAQ&#58; TWST), </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">a core mid-cap growth and value equity company in the life sciences segment of the health care sector</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, today reported financial results and business highlights for the fourth quarter and full year fiscal 2024 ended September&#160;30, 2024. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#34;Exiting fiscal 2024, we saw another quarter of record revenue and our seventh consecutive quarter of revenue growth. We continue to leverage our proprietary platform to add to our portfolio of solutions that deliver growth and margin expansion including our Express portfolio, NGS tools and recently, Twist-developed enzymes. We ended the quarter and the year exceeding our guidance across the board, closing out the fiscal year with </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$313.0 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> in revenue, a gross margin of 45.1% in 4QFY24 and a strong cash position,&#34; said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Dr. Leproust continued, &#34;As we head into fiscal 2025, we're building on this momentum as we continue our final push toward achieving adjusted EBITDA breakeven while investing in research and development to deliver precision, efficiency and scalability in products and services that continue to generate profitable growth.&#34; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:132%">See &#34;Non-GAAP Information&#34; below for a discussion of the measure adjusted EBITDA.</font></div><div><font><br></font></div><div id="id68af8dbab7b4e56b068b027baa5670e_4"></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%">FISCAL </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">2024</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%"> FINANCIAL RESULTS</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.5pt">Revenue</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#58; Total revenues for fiscal 2024 grew to $313.0 million compared to $245.1 million for fiscal 2023.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.11pt">SynBio revenue grew 26% to </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$123.5 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> for fiscal 2024 compared to </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$98.2 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> for fiscal 2023. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:104.4pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.11pt">NGS revenue grew 37% to </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$169.1 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> for fiscal 2024 compared to </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$123.7 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> for fiscal 2023.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.11pt">Biopharma revenue was </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$20.3 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> for fiscal 2024 compared to </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$23.2 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> for fiscal 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.5pt">Orders</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#58; Total orders received for fiscal 2024 grew to $344.2 million compared to $263.8 million for fiscal 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Cost of Revenues</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#58; Cost of revenues for fiscal 2024 was $179.6 million compared to $155.4 million for fiscal 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Gross Margin</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#58; Gross margin for fiscal 2024 increased to 42.6% compared to 36.6% for fiscal 2023. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Research and Development Expenses</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#58; Research and development expenses for fiscal 2024 decreased to $90.9 million compared to $106.9 million for fiscal 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Selling, General and Administrative Expenses&#58;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> Selling, general and administrative expenses for fiscal 2024 were $218.4 million compared to $189.7 million for fiscal 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Net Loss&#58;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> Net loss attributable to common stockholders for fiscal 2024 was $208.7 million, or $3.60 per share, compared to $204.6 million, or $3.60 per share, for fiscal 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Adjusted EBITDA&#58; </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Adjusted EBITDA for fiscal 2024 was $(93.5) million compared to $(147.3) million in fiscal 2023. See the table included in this release for a reconciliation between our adjusted EBITDA and net loss attributable to common stockholders, the most directly comparable GAAP financial measure. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Cash Position&#58;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> As of September&#160;30, 2024, the company had $276.4 million in cash, cash equivalents and short-term investments.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%">FISCAL </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">2024</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%"> FOURTH QUARTER FINANCIAL RESULTS</font></div><div style="padding-left:0.36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Revenue&#58;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> Total revenues for the fourth quarter of fiscal 2024 grew 27% to $84.7 million compared to $66.9 million for the same period of fiscal 2023.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.11pt">SynBio revenue grew 28% to </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$33.9 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> for the fourth quarter of fiscal 2024 compared to </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$26.5 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> for the same period of fiscal 2023. </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.11pt">NGS revenue grew 23% to </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$45.5 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> for the fourth quarter of fiscal 2024 compared to </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$37.1 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> for the same period of fiscal 2023.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.11pt">Biopharma revenue was </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$5.3 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> for the fourth quarter of fiscal 2024 compared to </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$3.4 million</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> for the same period of fiscal 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.5pt">Orders&#58;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> Total orders received for the fourth quarter of fiscal 2024 grew 24% to $88.2 million compared to $71.1 million for the same period of fiscal 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Cost of Revenues&#58;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> Cost of revenues for the fourth quarter of fiscal 2024 increased to $46.5 million compared to $42.4 million for the same period of fiscal 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Gross Margin</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#58; Gross margin for the fourth quarter of fiscal 2024 increased to 45.1% compared to 36.6% for the same period of fiscal 2023. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:104.4pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Research and Development Expenses&#58;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> Research and development expenses for the fourth quarter of fiscal 2024 decreased to $21.1 million compared to $23.7 million for the same period of fiscal 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Selling, General and Administrative Expenses&#58;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> Selling, general and administrative expenses for the fourth quarter of fiscal 2024 were $53.1 million compared to $47.4 million for the same period of fiscal 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.5pt">Net Loss&#58;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> Net loss attributable to common stockholders for the fourth quarter of fiscal 2024 decreased to $34.7 million, or $0.59 per share, compared to $46.2 million, or $0.81 per share, for the same period of fiscal 2023.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%;padding-left:14.15pt">Adjusted EBITDA&#58; </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Adjusted EBITDA for the fourth quarter of fiscal 2024 was $(17.0) million compared to $(26.4) million for the same period of fiscal 2023. See the table included in this release for a reconciliation between our adjusted EBITDA and net loss attributable to common stockholders, the most directly comparable GAAP financial measure.</font></div><div><font><br></font></div><div id="id68af8dbab7b4e56b068b027baa5670e_7"></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Recent Highlights&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.5pt">Shipped products to approximately </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">3,562</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> customers in fiscal </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2024</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">, versus approximately </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">3,450</font><font style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">in fiscal </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2023</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:14.5pt">Shipped approximately </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">772,000</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> genes during fiscal </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2024</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">, compared with approximately </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">634,000</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> in fiscal </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2023</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%;padding-left:13.8pt">Strengthened executive team with the appointment of Mike Fero as chief information officer. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%;padding-left:14.15pt">Entered into a royalty purchase agreement with XOMA Royalty Corporation for $15 million cash in October 2024. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%;padding-left:14.15pt">Expanded DNA synthesis offering with the launch of Gene Fragments with increased lengths ranging from 1.8kb to 5.0kb. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%;padding-left:14.15pt">Launched a joint Transaminase Enzyme Screening Kit, a curated collection of forty-eight highly diverse transaminase enzymes ready for in-house screening and evaluation, with bitBiome. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%;padding-left:14.15pt">Launched the FlexPrep&#8482; Ultra-High Throughput Library Preparation Kit, designed with a proprietary Twist-developed enzyme to enable throughput at a low cost, and accelerate the adoption of NGS by microarray users in population and agricultural genomics. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%;padding-left:14.15pt">Announced a collaboration with Absci to design a novel therapeutic using generative AI. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:132%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%;padding-left:13.8pt">Released 2024 ESG report and quantified the carbon footprint of Twist's oligo manufacturing process specific to NGS target enrichment panels. For a year&#8217;s production of Twist panels, the process emitted the equivalent CO</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7.15pt;font-weight:400;line-height:132%;position:relative;top:1.55pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%"> emissions of about 2.4 tanker trucks of gasoline compared to over 6,000 tanker trucks&#8217; worth of gasoline for the industry standard 96-well plate approach.</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7.15pt;font-weight:400;line-height:132%;position:relative;top:-3.85pt;vertical-align:baseline">1</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">&#8226;</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%;padding-left:14.15pt">Achieved LEED Certification from the U.S. Green Building Council for Wilsonville facility for meeting sustainability standards for building, operations and maintenance. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:104.4pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div id="id68af8dbab7b4e56b068b027baa5670e_10"></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Fiscal </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">2025</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%"> Financial Guidance</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The following statements are based on Twist&#8217;s current expectations for fiscal </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2025. </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The following statements are forward-looking, and actual results could differ materially depending on market conditions and the factors set forth under &#8220;Forward-Looking Statements&#8221; below.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">For the full fiscal year </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2025</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">, Twist expects</font><font style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:132%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:132%;padding-left:14.15pt">Total revenue is expected to be in the range of $367 million to $377 million, growth of 17 to 20 percent year over year, including&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.11pt">SynBio revenue of $142 to $146 million, growth of 15 to 18 percent</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.11pt">NGS revenue of $204 to $209 million, growth of 20 to 24 percent </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.11pt">Biopharma revenue of $21 to $22 million, growth of 5 to 8 percent</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.15pt">Gross margin is projected to be approximately 48% for fiscal 2025 with quarterly sequential improvements and 4QFY25 gross margin of 50%</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.15pt">Adjusted EBITDA of approximately $(60) to $(65) million for fiscal 2025</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">For the first quarter, Twist expects&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.15pt">Total revenue of approximately $87 million</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#222222;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.11pt">SynBio revenue of approximately $34 million, growth of 26% year over year</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.11pt">NGS revenue of approximately $48 million, growth of 22% year over year</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.11pt">Biopharma revenue of approximately $5 million</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.11pt">Adjusted EBITDA of approximately $(20) million with sequential improvements throughout 2025</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:132%">Non-GAAP Information</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">This release includes EBITDA and adjusted EBITDA, which are non-GAAP financial measures, for the periods presented. EBITDA is defined as net loss adjusted to exclude interest income, interest expense, income tax expense and depreciation and amortization. Adjusted EBITDA is defined as net loss adjusted to exclude interest income, interest expense, income tax expense, depreciation and amortization, other income&#47;expense, net, stock-based compensation expense, restructuring and other costs, impairment of long-lived assets, change in fair value of contingent considerations and holdbacks, and other items detailed in the reconciliation table below that we believe are not indicative of our ongoing results. These non-GAAP measures are not in accordance with, or an alternative for, measures prepared in accordance with generally accepted accounting principles (GAAP) and may be different from non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:104.4pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">set of accounting rules or principles. We believe that these non-GAAP financial measures, when considered together with our financial information prepared in accordance with GAAP, can enhance investors&#8217; and analysts&#8217; ability to meaningfully compare our results from period to period and to our forward-looking guidance, and to identify operating trends in our business. However, non-GAAP information is not superior to financial measures calculated in accordance with GAAP, is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. A reconciliation table of the most comparable GAAP financial measure to the non-GAAP financial measures is included at the end of this press release. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">A reconciliation of adjusted EBITDA for fiscal 2025 and the first quarter of fiscal </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:132%">2025</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%"> to a corresponding GAAP financial guidance measure is not available on a forward-looking basis because the Company does not provide guidance on GAAP net loss and is not able to present the various reconciling cash and non-cash items between GAAP net loss and adjusted EBITDA without unreasonable effort. In particular, stock-based compensation expense is impacted by the Company&#8217;s future hiring and retention needs, as well as the future fair market value of its common stock, all of which is difficult to predict and is subject to change. The actual amount of these expenses during fiscal </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:132%">2025</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%"> and the first quarter of fiscal 2025 will have a significant impact on Twist&#8217;s future GAAP financial results.</font></div><div style="padding-left:0.36pt"><font><br></font></div><div id="id68af8dbab7b4e56b068b027baa5670e_13"></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Conference Call Information</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">The company plans to hold a conference call and live audio webcast for analysts and investors at 8&#58;00 a.m. Eastern Time today to discuss its financial results and provide an update on the company&#8217;s business. The conference call will be webcast live through the Investor Relations section under the &#8220;Company&#8221; tab at www.twistbioscience.com. Those parties interested in participating via telephone must register on the Company&#8217;s Investor Relations website or by clicking here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Calculated Twist internal data using Dr. Oligo benchmark January 2021. Comparison calculated using the EPA Greenhouse Gas Equivalencies Calculator</font></div><div id="id68af8dbab7b4e56b068b027baa5670e_16"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%">About Twist Bioscience</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by &#8220;writing&#8221; DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:104.4pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Follow us on&#160;LinkedIn&#160;&#124;&#160;X&#160;&#124;&#160;YouTube&#160;&#124;&#160;Instagram</font></div><div><font><br></font></div><div id="id68af8dbab7b4e56b068b027baa5670e_19"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Legal Notice Regarding Forward-Looking Statements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">This press release contains forward-looking statements. All statements other than statements of historical facts contained herein are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, projections under the heading &#8220;Fiscal </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:132%">2025</font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%"> Financial Guidance&#8221; statements regarding future growth and expansion, timing of the development of DNA </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:132%">data storage solutions, revenue growth, </font><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">estimated annual revenues, ability and timing to achieve profitability and ability to increase gross margins and Twist Bioscience&#8217;s other expectations regarding its future operations plans and financial performance, introduction of new products, and newly announced partnerships. Forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause Twist Bioscience&#8217;s actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the ability to attract new customers and retain and grow sales from existing customers&#59; the ability of Twist Bioscience to achieve sufficient revenue to achieve or maintain positive cash flow from operations or profitability in any given period&#59; ability to obtain financing when necessary&#59; risks and uncertainties of rapidly changing technologies and extensive competition in synthetic biology that could make the products Twist Bioscience is developing obsolete or non-competitive&#59; ability to expand DNA synthesis manufacturing capacity&#59; dependence on one supplier for a critical component&#59; dependence on key personnel&#59; additional regulations that could increase Twist Bioscience's costs and delay commercialization efforts&#59; and the ability to maintain and enforce intellectual property protection. For a description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Twist Bioscience&#8217;s business in general, see Twist Bioscience&#8217;s risk factors set forth in Twist Bioscience&#8217;s Annual Report on Form 10-K expected to be filed with the Securities and Exchange Commission on November 18, 2024. Any forward-looking statements contained in this press release speak only as of the date hereof, and Twist Bioscience specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:132%">For Investors&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:104.4pt;width:100%"><div><font><br></font></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">Angela Bitting</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">SVP, Corporate Affairs</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">925-202-6211</font></div><div><font style="background-color:#ffffff;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">abitting&#64;twistbioscience.com</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:700;line-height:132%">For Media&#58;</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">Amanda Houlihan</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">Communications Manager</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">774-265-5334</font></div><div><font style="background-color:#ffffff;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:132%">ahoulihan&#64;twistbioscience.com</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:133%"><br>###</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id68af8dbab7b4e56b068b027baa5670e_22"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Twist Bioscience Corporation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Condensed Consolidated Statements of Operations</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(Unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(in thousands)</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.259%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.162%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.166%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three months ended September 30, </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Twelve months ended September 30, </font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(In thousands, except per share data)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#160;</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#160;</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">84,710&#160;</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">66,946&#160;</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">312,974&#160;</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">245,109&#160;</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cost of revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">46,477&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">42,424&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">179,625&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">155,380&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21,134</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23,745</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">90,852</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">106,894</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling, general and administrative</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53,143</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">47,391</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">218,398</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">189,738</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Restructuring and other costs </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">332</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,384</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value of contingent considerations and holdbacks</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5,913)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Impairment of long-lived assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,165</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44,930</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,785</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total operating expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">120,754&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">117,057&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">533,805&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">462,268&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss from operations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(36,044)</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(50,111)</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(220,831)</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(217,159)</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest income</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,620&#160;</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,893&#160;</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,344&#160;</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,365&#160;</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(28)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(29)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income (expense), net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,299)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(245)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,650)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(667)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income tax (expense) benefit</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">96</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">221</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(560)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,152)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss attributable to common stockholders</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(34,655)</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(46,243)</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(208,726)</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(204,618)</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss per share attributable to common stockholders&#8212;basic and diluted</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.59)</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.81)</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3.60)</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3.60)</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average shares used in computing net loss per share attributable to common stockholders&#8212;basic and diluted</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">58,554</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">57,279</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">58,016</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">56,885</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div id="id68af8dbab7b4e56b068b027baa5670e_25"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Twist Bioscience Corporation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Condensed Consolidated Balance Sheets </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(Unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(in thousands)</font></div><div><font><br></font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(In thousands)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br>2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br>2023</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">226,316&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">286,470&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Short-term investments</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">50,083</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">49,943</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">34,903</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44,064</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,078</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32,063</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,396</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,716</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">346,776&#160;</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">424,256&#160;</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">102,520</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">131,830</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease right-of-use assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">58,829</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">71,531</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other non-current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">106,198</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">148,786</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">614,323&#160;</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">776,403&#160;</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Liabilities and stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,630&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,052&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,104</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,754</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued compensation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">33,650</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">25,818</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current portion of operating lease liability</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,805&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,896&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,817</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,803</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total current liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">71,006&#160;</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">73,323&#160;</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liability, net of current portion</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">70,221</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">79,173</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other non-current liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">407</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">475</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">141,634&#160;</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">152,971&#160;</font></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">472,689&#160;</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">623,432&#160;</font></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total liabilities and stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">614,323&#160;</font></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">776,403&#160;</font></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id68af8dbab7b4e56b068b027baa5670e_549755814026"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Twist Bioscience Corporation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted EBITDA </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">(in thousands)</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The following table sets forth a reconciliation between our Adjusted EBITDA and net loss attributable to Twist Bioscience Corporation, the most directly comparable GAAP financial measure, for each of the periods presented&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.611%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three months ended September 30, </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Twelve months ended September 30, </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(In thousands)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">GAAP net income </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(34,655)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(46,243)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(208,726)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(204,618)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Add (Deduct) adjustments&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest income</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,620)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,893)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(15,344)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(14,365)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">28</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">29</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Income tax expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(96)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(221)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">560</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,152</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,656</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,500</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31,432</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">29,310</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">EBITDA</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(31,687)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(41,856)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(192,050)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(188,517)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Add (Deduct) adjustments&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income&#47;expense, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,299</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">245</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,650</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">667</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stock-based compensation expense </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,347</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,747</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">50,925</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">30,278</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Restructuring and other costs</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">332</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,384</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Impairment of long-lived assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,165</font></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">44,930</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,785</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value of contingent considerations and holdbacks</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5,913)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Adjusted EBITDA </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(17,042)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(26,367)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(93,545)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(147,315)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>twist-20241118.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:912c04d7-fd84-4786-a4ec-b75bcadce53d,g:91d154d6-3648-41c0-b2fb-41e7928a8baf-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:twist="http://imetrix.edgar-online.com/20241118" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://imetrix.edgar-online.com/20241118">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="twist-20241118_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="twist-20241118_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://imetrix.edgar-online.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>twist-20241118_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:912c04d7-fd84-4786-a4ec-b75bcadce53d,g:91d154d6-3648-41c0-b2fb-41e7928a8baf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_08213687-4e11-4bea-813e-563a15280fb6_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ac73b8b4-0854-4029-becd-24cd4e6788a6_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_2b55e809-32c6-417a-b8cf-29a5c22ddb11_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8772f6ad-c948-429e-b01a-e8a7f269b651_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6c9a068d-57c0-403b-9d90-bc693290cd2c_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_42b01d28-a9fa-4e2b-97f7-27a781726774_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_33e9eac5-c55f-4d8a-8adf-6d73f2972ddc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_9b219aac-44b9-4c01-9060-e697e7e982af_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f6ade1fb-51c0-4d4a-85c0-da7d1ad70ffa_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c6bd7efd-94c6-41ca-bfc9-c7bb0a5374a6_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_de74b65e-3f3e-4f00-8ca6-e03b3d7a310a_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_942573eb-60a3-4091-be6c-100309ee31e4_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a35203cd-2a03-4897-9d2d-1332dd5b497a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_cf498ccd-58c8-463d-9a52-2f59d8017f63_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0a6f154f-3f1a-43d1-a7c4-54725ed0f454_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a2dce8eb-5d32-4648-90df-7ae7279ec9e9_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_57a1455d-1c30-4d30-90b6-ae035aebc522_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2aee441c-0cdf-4115-8a87-dd283cdd211b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_b59c6235-2483-417b-97bf-705cc95ce861_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1f96b943-e929-4355-9df0-8a4ccb3cada2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a2d6e3a6-59b2-4bb4-b153-f0d2864ffc66_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_eb017a58-7ddf-4b10-ad9e-e8bc0affa9a8_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>twist-20241118_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:912c04d7-fd84-4786-a4ec-b75bcadce53d,g:91d154d6-3648-41c0-b2fb-41e7928a8baf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://imetrix.edgar-online.com/role/CoverPage" xlink:type="simple" xlink:href="twist-20241118.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://imetrix.edgar-online.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_86cfd6e7-ef89-4183-894f-aa79de277a78" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_DocumentType_86cfd6e7-ef89-4183-894f-aa79de277a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e167c17d-874f-4ad0-8364-f1dc52bc3c16" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_DocumentPeriodEndDate_e167c17d-874f-4ad0-8364-f1dc52bc3c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a5c708d4-64a1-48f1-b16f-b6de3f641075" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_EntityRegistrantName_a5c708d4-64a1-48f1-b16f-b6de3f641075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_44547eee-0c27-4289-9e7d-561176f79104" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_EntityIncorporationStateCountryCode_44547eee-0c27-4289-9e7d-561176f79104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_26686050-19d1-48d4-8741-88cd53955677" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_EntityFileNumber_26686050-19d1-48d4-8741-88cd53955677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7d0add03-dc4b-4672-8fea-2031b93106e9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_EntityTaxIdentificationNumber_7d0add03-dc4b-4672-8fea-2031b93106e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_603ff0df-6168-428d-b2e4-78f3f34f23a8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_EntityAddressAddressLine1_603ff0df-6168-428d-b2e4-78f3f34f23a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5d3f1996-8de5-4e6e-870c-711308790d46" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_EntityAddressCityOrTown_5d3f1996-8de5-4e6e-870c-711308790d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0f4ad3d1-1162-44f6-9969-a7eff7e773c9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_EntityAddressStateOrProvince_0f4ad3d1-1162-44f6-9969-a7eff7e773c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e827d56c-caf9-496d-b069-a4185d48b8ad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_EntityAddressPostalZipCode_e827d56c-caf9-496d-b069-a4185d48b8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c148e61b-0142-4fc7-a2ff-ed704ec3f26d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_CityAreaCode_c148e61b-0142-4fc7-a2ff-ed704ec3f26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_dfe9e70b-2c96-4ef5-929f-5e418d8cc346" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_LocalPhoneNumber_dfe9e70b-2c96-4ef5-929f-5e418d8cc346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_961d164c-2e1c-4ccb-bc7c-ac4491b2f96a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_WrittenCommunications_961d164c-2e1c-4ccb-bc7c-ac4491b2f96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_b2c5dc3b-fa2a-4fe1-8390-7102a81a2beb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_SolicitingMaterial_b2c5dc3b-fa2a-4fe1-8390-7102a81a2beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_9c1a8dfa-8ccf-49fb-8c9d-701459439ec9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_PreCommencementTenderOffer_9c1a8dfa-8ccf-49fb-8c9d-701459439ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_da104164-a34b-4a2d-88e1-7ea28b31c1ef" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_da104164-a34b-4a2d-88e1-7ea28b31c1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8d20b363-7218-4ea2-955d-7cc4fab31d90" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_Security12bTitle_8d20b363-7218-4ea2-955d-7cc4fab31d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f059b582-df83-43ec-88cd-9e8154f27707" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_TradingSymbol_f059b582-df83-43ec-88cd-9e8154f27707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ca7c7254-f57b-495c-b42f-799ffe16d27a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_SecurityExchangeName_ca7c7254-f57b-495c-b42f-799ffe16d27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_eea7b0a9-0320-41a2-85eb-a5602dd1ad35" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_EntityEmergingGrowthCompany_eea7b0a9-0320-41a2-85eb-a5602dd1ad35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c1fb85c1-5821-46fe-9d40-2520b82469ed" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_AmendmentFlag_c1fb85c1-5821-46fe-9d40-2520b82469ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_98f0b0fc-4590-4041-bf88-39a04285b701" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b9b2e192-9fdb-43be-8687-945c080a8b40" xlink:to="loc_dei_EntityCentralIndexKey_98f0b0fc-4590-4041-bf88-39a04285b701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_2.jpg
<TEXT>
begin 644 image_2.jpg
MB5!.1PT*&@H    -24A$4@  !D    ,@" (   #THCD-  !<&TE$051X7NS=
M/VL<U_\O\%OY&>09N-3M4EA]B!^ ] #N);55N'5G^(&*5,;W-JEBE6[D0!J!
M" XI;$' =K,87,B%C"&%A< 8W/B>F^4G])W1K';/?,[,F=W7BP\_OC]G-7]V
M9\[9\]Z9,__C&P    !4['\T_P$     :B+  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP     JB;  @   *!J BP     JB;  @
M *!J BP     JB;  @   *!J BP  "#,IZ]??GW_^OZ;HQ_^.DAU^^CQK</_
M^OZ/7^;_;_KW9Q_>IM<T_PP %A)@ 0   9[_<[KSXNFMP_]:IM(KT^N;BP"
M#@(L  "@E^?_G/[PUT$[I;JQTE^)L0!8A@ +  #(=__-43N96JD>SOYL+A0
M_I, "P  R/'IZY>\"Z_:E99C8BP %A!@ 0  *_OT]<OW?_S2CJ*R*RU-A@5
M%P$6  "PLJAKKZY66F9S-0#P+P$6  "PFH>S/]OQ4TB9#PN :PFP  " %;PZ
M_]@.G@(K+;^Y2@ VG@ +  !808F;!Z^6&PD!:!-@ 0  RRI]^=6\GO]SVEPQ
M )M-@ 4  "SKI[]_:^=-X;7SXFESQ0!L-@$6  "PK.]^_[F=-Y6H3U^_--<-
MP 838 $  $MY_L]I.VDJ5,\^O&VN'H -)L "  "6\NC=RW;25*@>SOYLKAZ
M#2;  @  EG+_S5$[:2I4IL$"X"H!%@  L)0?_CIH)TV%*JVKN7H -I@ "P"
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M_^?TT;N7#V=_SBN-_$UTQ=J8'^%7J_D*@"D38 $   !0-0$6     %438 $
M  !0-0$6     %438 $   !0-0$6     %438 $   !0-0$6     %438 $
M  !0-0$6     %438 $   !0-0$6     %438 $   !0-0$6     %438 $
M  !0-0$6     %438 $   !0-0$6     %438 $   !0-0$6     %438 $
M  !0-0$6     %438 $   !0-0$6     %438 $   !0-0$6     %438 $
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M-Z>W_KT4Z]7YQ^:B@:$(L   :I2&23?.S[)DN9T0V&0AZ=6\4K,LPX*Q"+
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M#$: !0 POL&F:[EEN 5L@';35Z@\&0,&(\ " !B?  L@4+OI*U?-=0-E"+
M ,8GP ((U&[ZRE5SW4 9 BP @/$-&6"9<AA8>]__\4N[]2M1:47-=0-E"+
M ,;W[,/;]KBH4'D*(;#V=EX\;;=^)<HUK3 8 18 P/B&? IA6E=S]0#KY=&[
ME^W6KT3=?W/47#=0A@ + * *[7%1B?KN]Y^;*P98.Z>?S]L-8(EZ]N%M<]U
M&0(L ( J#'/#BPFP@ TQS#18G[Y^::X8*$. !0!0A5_?OVX/C<++_8/ AAB@
M4?63  Q)@ 4 4(OO?O^Y/4 *+),- QOE]M'C=DL86'X2@"$)L   :O%P]F=[
M@!18K\X_-E<)L+Z*/A_#3P(P, $6 $!%RETO\'#V9W-E .ON_INC=GO8O[[[
M_>?3S^?-E0$E";   "KRZOQC>Z34OUPI &RLU "V6\6>]>O[U\W5 (4)L
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MS:77Y_#PL+WE&36)6R:CTKIY3>+SI7X"+-95:G)[/N*VVKJSO3V)WZB8- /
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MJP"+HMJ'7$:-^R038%51/90!(-D$6&32?K'A)CT-5N#E2!DURD5G@1-@N5Z
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MFP"+3-HOF.@T6%$G;\\:;-P2^,C%X6_V9 -%G:$"+,J)"K"&_/$&Z"^JAS(
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M_8*&P._QS47WL[.[VU[%JK5@7I+VBS/J^/BXN=P> N_HO/;&22@GJGL58#&
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M@Q4RE_FJ-_2%S/_5)[8+'#49G#"6J.Y5@,6( EOC.BMUT.D4TU.P::)Z* -
ML@FPR*3]@BZ!3Q//OI_NR<%!>VFKUJJWT86D9JF:RUU:R%V36R; 8E11W:L
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M(U^^9K-9<SN@,E'=JP"+(76E5_/:V=V==//[X,&#]DYE5WHWFBN B8CJH0P
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M";#(I/V"0*5OHZM\!JA"SWNZK&%N18$04=VK (M P]SJOJY5>1<,RXOJH0P
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M_75G'F_=6.EE\]?/LRIQ%<"D";      J)H "P   ("J";      J)H "P
M ("J";      J)H "P   ("J";      J)H "P   ("J";      J)H "P
M ("J";      J)H "P   ("J";      J)H "P   ("J";      J)H "P
M ("J";      J)H "P   ("J";      J)H "P   ("J";      J)H "P
M ("J";      J)H "P   ("J";      J)H "P   ("J";      J)H "P
M ("J";      J)H "P   ("J";      J)H "P   ("J";      J)H "P
M ("J";      J)H "P   ("J";      J)H "P   ("J";      J)H "P
M ("J";      J)H "P   ("J";      J)H "P   ("J";      J)H "P
M ("J";      J)H "P   ("J";      J)H "P   ("J";      J)H "P
M ("J";      J)H "P   ("J";      J)H "P   ("J";      J)H "P
M ("J";      J)H "P   ("J";      J)H "P   ("J";      J)H "P
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MOX&+KT0;($GL.IB;KRMCZOE"5\O6KHS&8=R/)J2=67R/[0#-]=0/,-:;  L
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M;XZ*;D ?H[QCA73M2_-U94P]7[CQE%SP]+T;=W.LCV;J'\I5Z[0OK!\!%@!
MC;J&>;>/'C]L/92J43LOGJ:!7-=55Y<UY-U;70/+TOE%U]MX_\U1\Z6K&&5W
MTN?57N.UE38O'0,/_WT>7]%-6MXH[U@A7?O2?%T97?G"3W__EM[,[!KF5N)O
MW:?DU4RY:Q_GM2!V'^NCZ=K@*88^7?LRE0.,]2;  @"HT?..85Y4#3SY=]?
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M5WIKFC^K3/T 8[T)L.!F71UM2"WNK0'63U>,$E)IA--<WV1U]3[9'<>"Z'"
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M2L*DZ]W/TS"5:LZO7M;>UP^'-Y>B*X 689 ,0V7+284[)^_??O_R^<^O^)$
M (R=  N&<36[_?C[Q\'U^?[%<9A]A0I_"'\-_SB]G\5; ] J#*IG?Z?S<?7S
MGU_AS\92 (!M)L "    H&H"+     "J)L "    H&H"+     "J)L "
MH&H"+     "J)L "    H&H"+     "J)L "    H&H"+     "J)L "
MH&H"+     "J)L "    H&H"+     "J)L "    H&H"+     "J)L "
MH&H"+     "J)L "    H&H"+     "J)L "    H&H"+     "J)L "
MH&H"+     "J)L "    H&H"+     "J)L "    H&H"+     "J)L "UF]Z
M/SO[.WVNJ]EMO 5LIKO'A]"E#V\N#Z[/YZ6' P! #P(L8#W"Q/[C[Q_[%\<[
M)^\G__N_9KWY]BE,^Z?WL_B14+VKV>V[GZ>[IT?-CCVOT.U#YP\_ O$C 0"
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M#U@6JK N0]V4H*6F][.X50  V%8"+""7,/UNSLD'+XNP*._SGU_-KCAXZ=L
M /!,@ 7DDN\*02]KY^1]W#!DMG]QW.R*@]?NZ5'<,   ;"L!%I!+@7.LYO7Y
MSZ^X;<CF[O&AV0DSU=7L-FX>  "VD@ +R*+D)-_EKBFIS/F#\SJ\N8R;!P"
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M+O<OCM]\^Q1JY^1]J/F?PS\>7)\[81   *B3  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " J@FP     *B:  L
M  " J@FP     *B:  L   " J@FP     *B:  L   " JOT_)5X7:%!I6E
+    245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46656130253136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Nov. 18, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 18,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Twist Bioscience Corporation<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-2058888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">681 Gateway Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">719-0671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TWST<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001581280<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M5&V&'O7>3SR+Y<JZ$_YHD+,EC[C],Y]J./(KE41D7!JA)-%\,?3&].8V[+B
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MRE.[/L4M>ZKY>0S#XWK>;IW!90(KHJ^+Q9'\X7JM9+7_4]RN?R![-*8 LE9
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M> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( (,Z<EF7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ @SIR61E%%?4W 0
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M)H]:1NO<2KGW\$JV''..?[3\ 5!+ P04    " "#.G)9)!Z;HJT   #X 0
M&@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I
M0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LID
MR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\
M./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6
M?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ @SIR6660>9(9 0
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M<',O87!P+GAM;%!+ 0(4 Q0    ( (,Z<EEP [C<[@   "L"   1
M      "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( (,Z<EF9
M7)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N
M>&UL4$L! A0#%     @ @SIR66@[$CL[!   >A   !@              ("!
M#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( (,Z<EF?
MH!OPL0(  .(,   -              "  7X,  !X;"]S='EL97,N>&UL4$L!
M A0#%     @ @SIR69>*NQS     $P(   L              ( !6@\  %]R
M96QS+RYR96QS4$L! A0#%     @ @SIR61E%%?4W 0  )P(   \
M     ( !0Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( (,Z<EDD'INB
MK0   /@!   :              "  :<1  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( (,Z<EEED'F2&0$  ,\#   3
M  "  8P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  -83
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="twist-20241118.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="twist-20241118.htm">twist-20241118.htm</File>
    <File>twist-20241118.xsd</File>
    <File>twist-20241118_lab.xml</File>
    <File>twist-20241118_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "twist-20241118.htm": {
   "nsprefix": "twist",
   "nsuri": "http://imetrix.edgar-online.com/20241118",
   "dts": {
    "inline": {
     "local": [
      "twist-20241118.htm"
     ]
    },
    "schema": {
     "local": [
      "twist-20241118.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "twist-20241118_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "twist-20241118_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://imetrix.edgar-online.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "twist-20241118.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "twist-20241118.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://imetrix.edgar-online.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001628280-24-048173-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-048173-xbrl.zip
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MC^/%W!D-;Q>/1#RE X=[]S]T+]VS\H=[_P=02P,$%     @ @SIR68/&/2I
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MW2N6C8W&RD"HQQPXS&NY;%+(;S3&;ED _ FBW4^G<--XPL)IP:ZP_ES))Y6
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M9GRO^LC3XSGD\Z=^Y$WAGU$Z#G[Y/U!+ 0(4 Q0    ( (,Z<ED3CFA(@@\
M "=S   2              "  0    !T=VES="TR,#(T,3$Q."YH=&U02P$"
M% ,4    " "#.G)924T?G6P"   A!P  $@              @ &R#P  ='=I
M<W0M,C R-#$Q,3@N>'-D4$L! A0#%     @ @SIR62E8;]<""@  ?50  !8
M             ( !3A(  '1W:7-T+3(P,C0Q,3$X7VQA8BYX;6Q02P$"% ,4
M    " "#.G)9]-)C K<&  #[,   %@              @ &$'   ='=I<W0M
M,C R-#$Q,3A?<')E+GAM;%!+ 0(4 Q0    ( (,Z<EF#QCTJ0"P  "== @ 7
M              "  6\C  !T=W-T+3(P,C0P.3,P>&5X.3DQ+FAT;5!+!08
1    !0 % $T!  #D3P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>twist-20241118_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="twist-20241118.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001581280</identifier>
        </entity>
        <period>
            <startDate>2024-11-18</startDate>
            <endDate>2024-11-18</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-23">0001581280</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-11-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Twist Bioscience Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-38720</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">46-2058888</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">681 Gateway Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">South San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">719-0671</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">TWST</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
